Hester Biosciences Limited (BOM:524669)
India · Delayed Price · Currency is INR 1,559.95
-18.80 (-1.19%)
At close: Feb 13, 2026
Hester Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 274.88 | 188.89 | 266.27 | 393.2 | 344.3 |
Depreciation & Amortization | 166.17 | 170.64 | 205.73 | 165.27 | 132.64 |
Other Amortization | 1.85 | 1.1 | 1.22 | 0.54 | 0.5 |
Loss (Gain) From Sale of Assets | 4.86 | -0.28 | -0.16 | -0.69 | 23.22 |
Loss (Gain) on Equity Investments | -41 | -46.09 | -44.09 | -4.23 | - |
Provision & Write-off of Bad Debts | 44.71 | 7.12 | 5.28 | 24.57 | 9.77 |
Other Operating Activities | 94.19 | 123.71 | 10.09 | -103.74 | 54.63 |
Change in Accounts Receivable | 16.15 | 3.95 | -249.65 | -87.79 | 82.47 |
Change in Inventory | 52.04 | 92.29 | -94.28 | -131.6 | 17.46 |
Change in Accounts Payable | 36.51 | -37.27 | 119.64 | -100.67 | 80.63 |
Change in Other Net Operating Assets | -5.25 | -22.23 | 15.91 | -67.74 | -165.09 |
Operating Cash Flow | 645.11 | 481.83 | 235.96 | 87.12 | 580.53 |
Operating Cash Flow Growth | 33.89% | 104.20% | 170.84% | -84.99% | 57.87% |
Capital Expenditures | -205.91 | -243.97 | -777.62 | -957.1 | -407.42 |
Sale of Property, Plant & Equipment | 2.74 | 0.55 | 0.25 | 1.79 | 0.42 |
Investment in Securities | 4.88 | -1.58 | 2.28 | -213.21 | 10.6 |
Other Investing Activities | 8.26 | 18.94 | 5.1 | 2.64 | 12.68 |
Investing Cash Flow | -190.03 | -226.06 | -769.99 | -1,166 | -383.72 |
Short-Term Debt Issued | - | - | 240.13 | 315.66 | - |
Long-Term Debt Issued | - | 204.74 | 320.44 | 1,033 | 182.11 |
Total Debt Issued | - | 204.74 | 560.57 | 1,349 | 182.11 |
Short-Term Debt Repaid | -17.72 | -275.07 | - | - | -292.64 |
Long-Term Debt Repaid | -316.5 | -232.66 | -172 | -181.18 | -118.44 |
Total Debt Repaid | -334.22 | -507.73 | -172 | -181.18 | -411.08 |
Net Debt Issued (Repaid) | -334.22 | -302.99 | 388.57 | 1,168 | -228.97 |
Common Dividends Paid | -51.68 | -68.53 | -85.07 | -85.07 | -56.15 |
Other Financing Activities | -131.27 | 110.59 | 114.08 | 32.48 | 102.93 |
Financing Cash Flow | -517.17 | -260.93 | 417.58 | 1,115 | -182.19 |
Foreign Exchange Rate Adjustments | -5.11 | 1.57 | 0.51 | -1.79 | -37.24 |
Net Cash Flow | -67.2 | -3.59 | -115.94 | 34.81 | -22.62 |
Free Cash Flow | 439.2 | 237.86 | -541.66 | -869.98 | 173.11 |
Free Cash Flow Growth | 84.65% | - | - | - | - |
Free Cash Flow Margin | 14.06% | 7.64% | -19.47% | -35.27% | 7.95% |
Free Cash Flow Per Share | 51.63 | 27.96 | -63.67 | -102.27 | 20.35 |
Cash Interest Paid | 131.27 | 149.41 | 125.92 | 25.38 | 40.25 |
Cash Income Tax Paid | 114.71 | 116.66 | 81.07 | 171.09 | 139.36 |
Levered Free Cash Flow | 361.29 | -23.69 | -507.55 | -764.94 | 13.92 |
Unlevered Free Cash Flow | 413.42 | 33.31 | -475.37 | -748.84 | 51.8 |
Change in Working Capital | 99.45 | 36.74 | -208.38 | -387.8 | 15.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.